Healthcare Equipment and Supplies
Company Overview of AngioScore, Inc.
AngioScore, Inc. designs, manufactures, and markets endovascular tools to treat cardiovascular and peripheral artery diseases. It offers AngioSculpt Scoring Balloon Catheter for the treatment of simple to complex coronary lesions, including in-stent restenosis and type C lesions; and treatment of peripheral artery diseases that address a range of peripheral lesions, including long diffuse lesions found in infrainguinal arteries. The company also provides AngioSculpt PTA Scoring Balloon Catheter for dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, infra popliteal, and renal arteries, as well as for the treatment of obstructive lesions of native or synthetic arteriovenous ...
5055 Brandin Court
Fremont, CA 94538
Founded in 2003
Key Executives for AngioScore, Inc.
Senior Vice President of Operations
Managing Director of International Business
Senior Vice President of Regulatory & Quality
Senior Vice President of U.S. Commercial Sales
Compensation as of Fiscal Year 2014.
AngioScore, Inc. Key Developments
AngioScore Launches New 200 mm Length AngioSculpt Scoring Balloon Catheters
Jul 9 14
AngioScore, Inc. launched its new 200 mm length AngioSculpt(R) PTA Scoring Balloon Catheters for the treatment of Peripheral Artery Disease (PAD) above-the-knee (ATK). The new AngioSculpt catheters received U.S. Food and Drug Administration (FDA) 510(k) clearance to be marketed for the dilatation of lesions in the iliac, femoral, iliofemoral, popliteal, infra-popliteal, and renal arteries, and to treat obstructive lesions of native or synthetic arteriovenous dialysis fistulae. They are not approved for use in the coronary or neuro-vasculature. The catheters incorporate 200 mm balloons in diameters of 4.0, 5.0 and 6.0 mm with a novel scoring element specifically designed for these longer balloons. The devices are expected to be particularly useful in treating the typical complex and long lesions found above-the-knee. The AngioSculpt balloon catheter was developed by AngioScore, Inc., which was acquired June 30, 2014, by The Spectranetics Corporation.
The Spectranetics Corporation, AngioScore, Inc. - M&A Call
May 27 14
To discuss merger agreement under which The Spectranetics Corporation will acquire AngioScore Inc
AngioScore, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 11:30 AM
Jan 10 14
AngioScore, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 11:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Thomas R. Trotter, Co-Founder, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 27, 2014